secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pacira BioSciences, Inc. (PCRX)
CIK:        0001396814
Form:       8-K
Filed at:   2025-04-22T23:59:59+00:00
Accession:  0001396814-25-000055
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Pacira Biosciences authorizes $300M share repurchase program through Dec 31, 2026
--------------------------------------------------------------------------------

- Board approved $300M stock buyback, effective immediately, replacing the May 7, 2024 program.
- Repurchases may be made on open market or via privately negotiated transactions at management's discretion.
- Program expires December 31, 2026; can be suspended or discontinued at any time by the company.
- No obligation to repurchase any specific number of shares under the authorization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1396814/000139681425000055/0001396814-25-000055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1396814/000139681425000055/pcrx-20250417.htm
  HTML page:      https://secwatch.observer/filing/0001396814-25-000055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer